Dr. Lai on Risk Factors Associated With Glioma

Video

Rose K. Lai, MD, clinical associate professor of Neurology, University of Southern California, discusses results of the Glioma International Case Control study.

Rose K. Lai, MD, clinical associate professor of Neurology, University of Southern California, discusses results of the Glioma International Case-Control Study.

In the study, which investigated risk factors in 4000 newly diagnosed patients with glioma, researchers sought to determine whether aspirin or non-steroidal anti-inflammatory agents (NSAIDs) were associated with a risk of disease. Earlier, smaller studies also looking at the association have demonstrated conflicting results, Lai says. However, recent evidence suggests that aspirin is associated with a lower risk of glioma.

Results of this study showed that aspirin was linked with a significant protective effect for patients with glioma; however, NSAIDs were only associated with reduced glioma risk in women.

<<<

View more from the 2016 AACR Annual Meeting

Related Videos
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Eric S. Christenson, MD
Samer A. Srour, MB ChB, MS
Rebecca L. Porter, MD, PhD
Deborah J. Wong, MD, PhD
Michael R. Migden, MD
Patrick I. Borgen, MD
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Reshma Lillaney Mahtani, DO